MGUS (monoclonal gammopathy of undetermined significance)
MGUS is a blood condition that affects blood cells called plasma cells. It is not in itself a type of blood cancer, but there is a small risk that MGUS can develop into a type of blood cancer.
Funding information
The following pharmaceutical companies and charitable organisations helped fund this information, but had no influence over it: Abbvie, AstraZeneca, Incyte, Jazz Pharmaceuticals, Kyowa Kirin, Roche, Sobi UK, The Garfield Weston Foundation, The Steel Charitable Trust and The Grace Trust.
What is MGUS?
MGUS is a blood condition affecting plasma cells. Most people with MGUS have no symptoms and will never need treatment.
MGUS and blood cancer
People with MGUS have a higher chance than normal of developing blood cancer, but it is still rare for this to happen.
MGUS diagnosis and monitoring
MGUS doesn’t need treatment, but you will have check-ups to monitor the condition.
MGUS and your mental health
Finding out you have MGUS can be worrying, and it’s important to look after your emotional health after diagnosis.
Many thanks to Dr Simon Stern and Dr Kamaraj Karunanithi for checking the accuracy of our information about MGUS.